Integra LifeSciences introduced the Integra® Panta® 2 TTC Arthrodesis Nail System for tibio-talo-calcaneal fusion of the ankle.
Panta 2’s carbon fiber targeting and compression device allows an unobstructed intra-op view of the nail to assist in positioning and verification that bone-to-bone contact is made. The device enables up to 12mm of compression to accommodate varying patient anatomies.
Panta 2 joins the XT revision ankle as new products cited by company leadership that will reinvigorate growth in Integra’s Orthopaedics and Tissue Technologies segment.
Sources: Integra LifeSciences; ORTHOWORLD Inc.
Integra LifeSciences introduced the Integra® Panta® 2 TTC Arthrodesis Nail System for tibio-talo-calcaneal fusion of the ankle.
Panta 2’s carbon fiber targeting and compression device allows an unobstructed intra-op view of the nail to assist in positioning and verification that bone-to-bone contact is made. The device enables up to 12mm of...
Integra LifeSciences introduced the Integra® Panta® 2 TTC Arthrodesis Nail System for tibio-talo-calcaneal fusion of the ankle.
Panta 2’s carbon fiber targeting and compression device allows an unobstructed intra-op view of the nail to assist in positioning and verification that bone-to-bone contact is made. The device enables up to 12mm of compression to accommodate varying patient anatomies.
Panta 2 joins the XT revision ankle as new products cited by company leadership that will reinvigorate growth in Integra’s Orthopaedics and Tissue Technologies segment.
Sources: Integra LifeSciences; ORTHOWORLD Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





